Therefore, we should conduct a prospective study to test the more favorable prognostic effect of the CPT-11/NDP regimen in the UGT1A1 polymorphism group than the wild-type group in cervical cancer patients with one or no lymph node metastases after radical hysterectomy. This evidence concerns the gene UGT1A1 and cervical cancer.